Which has higher immunization, hib3, Low & middle income or Naoero?

Naoero, at 97.0% against 75.7% in Low & middle income as of 2024.

How many years of comparable data are there for Low & middle income and Naoero?

16 years are reported by both, from 2009 to 2024.

Where does this data come from?

WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Low & middle income vs Naoero: Immunization, Hib3

Low & middle income

75.7%

in 2024

Naoero

97.0%

in 2024

Low & middle income rank

29th

Naoero rank

29th

Immunization, Hib3 over time

Low & middle income
Naoero

How they compare

Naoero currently reports 97.0% against 75.7% in Low & middle income, a difference of 21.3%.

That makes Naoero's figure about 1.3 times Low & middle income's.

Across all 16 years both countries report, Naoero has been ahead every year.

Low & middle income ranks 29th and Naoero ranks 29th of 43 groups.

Naoero has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade	Low & middle income	Naoero	Difference	Ahead
2000s	34.2%	99.0%	64.8%	Naoero
2010s	55.3%	92.0%	36.7%	Naoero
2020s	72.8%	96.8%	24.0%	Naoero

Averages of every year both report within each decade.

Frequently asked questions

Which has higher immunization, hib3, Low & middle income or Naoero?: Naoero, at 97.0% against 75.7% in Low & middle income as of 2024.
What is the difference in immunization, hib3 between Low & middle income and Naoero?: 21.3%, with Naoero ahead.
How many years of comparable data are there for Low & middle income and Naoero?: 16 years are reported by both, from 2009 to 2024.
How do Low & middle income and Naoero rank globally for immunization, hib3?: Low & middle income ranks 29th and Naoero ranks 29th of 43 groups.
Where does this data come from?: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Low & middle income vs Naoero: Immunization, Hib3. Statizoid, drawing on WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Retrieved 16 September 2026, from https://health.statizoid.com/compare/immunization-hib3-percent-of-children-ages-12-23-months/low-and-middle-income/naoero/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/compare/immunization-hib3-percent-of-children-ages-12-23-months/low-and-middle-income/naoero/">Low & middle income vs Naoero: Immunization, Hib3</a> — Statizoid

About this data

Indicator: Immunization, Hib3 (% of children ages 12-23 months)
Unit: % of children ages 12-23 months
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/)
Licence: CC BY 4.0 (World Bank Open Data)
Coverage: 234 places, 5,441 data points, 1990–2024
Last refreshed: 03 September 2026

Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.